LivaNova (LIVN) Net Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -218.00 |
| Dec 31, 2025 | 108.00 |
| Sep 30, 2025 | -22.00 |
| Jun 30, 2025 | 11,100.00 |
| Mar 31, 2025 | -12,066.00 |
| Dec 31, 2024 | 702.00 |
| Sep 30, 2024 | 521.00 |
| Jun 30, 2024 | 1,935.00 |
| Mar 31, 2024 | -1,949.00 |
| Dec 31, 2023 | 782.00 |
| Sep 30, 2023 | -295.00 |
| Jun 30, 2023 | -241.00 |
| Mar 31, 2023 | 219.00 |
| Dec 31, 2022 | 4,313.00 |
| Sep 30, 2022 | -4,900.00 |
| Jun 30, 2022 | 522.00 |
| Mar 31, 2020 | -48.00 |
| Dec 31, 2018 | -1.00 |
| Sep 30, 2018 | 122.00 |
| Jun 30, 2018 | 26.00 |
| Mar 31, 2018 | 2,701.00 |
| Dec 31, 2017 | -2,915.00 |
| Sep 30, 2017 | -39.00 |
| Jun 30, 2017 | 157.00 |
| Mar 31, 2017 | 855.00 |
| Dec 31, 2016 | -606.00 |
| Sep 30, 2016 | -185.00 |
| Jun 30, 2016 | 1,155.00 |
| Oct 18, 2015 | -5,249.00 |
| Jul 24, 2015 | 114.00 |